{"id":696,"date":"2025-03-03T21:56:08","date_gmt":"2025-03-03T21:56:08","guid":{"rendered":"https:\/\/perfusfind.com\/ic\/?p=696"},"modified":"2025-03-03T21:57:48","modified_gmt":"2025-03-03T21:57:48","slug":"limitations-of-spo2-fio2-ratio-for-classification-and-monitoring-of-acute-respiratory-distress-syndrome-an-observational-cohort-study","status":"publish","type":"post","link":"https:\/\/perfusfind.com\/ic\/index.php\/2025\/03\/03\/limitations-of-spo2-fio2-ratio-for-classification-and-monitoring-of-acute-respiratory-distress-syndrome-an-observational-cohort-study\/","title":{"rendered":"Limitations of SpO2 \/ FiO2-ratio for classification and monitoring of acute respiratory distress syndrome\u2014an observational cohort study"},"content":{"rendered":"

Abstract<\/h2>\n
\n

Background<\/h3>\n

The ratio of pulse-oximetric peripheral oxygen saturation to fraction of inspired oxygen (SpO2<\/sub>\/FiO2<\/sub>) has been proposed as additional hypoxemia criterion in a new global definition of acute respiratory distress syndrome (ARDS). This study aims to evaluate the clinical and theoretical limitations of the SpO2<\/sub>\/FiO2<\/sub>-ratio when using it to classify patients with ARDS and to follow disease progression.<\/p>\n

Methods<\/h3>\n

Observational cohort study of ARDS patients from three high-resolution Intensive Care Unit databases, including our own database ICU Cockpit, MIMIC-IV (Version 3.0) and SICdb (Version 1.0.6). Patients with ARDS were identified based on the Berlin criteria or ICD 9\/10-codes. Time-matched datapoints of SpO2<\/sub>, FiO2<\/sub>\u00a0and partial pressure of oxygen in arterial blood (PaO2<\/sub>) were created. Severity classification followed the thresholds for SpO2<\/sub>\/FiO2<\/sub>\u00a0and PaO2<\/sub>\/FiO2<\/sub>\u00a0of the newly proposed global definition.<\/p>\n

Results<\/h3>\n

Overall, 708 ARDS patients were included in the analysis. ARDS severity was misclassified by SpO2<\/sub>\/FiO2<\/sub>\u00a0in 33% of datapoints, out of which 84% were classified as more severe. This can be partially explained by imprecision of SpO2<\/sub>\u00a0measurement and equation used to transform SpO2<\/sub>\/FiO2<\/sub>\u00a0to PaO2<\/sub>\/FiO2.<\/sub>\u00a0A high dependence of SpO2<\/sub>\/FiO2<\/sub>-ratio on FiO2<\/sub>\u00a0settings was found, leading to major treatment effect and limited capability for tracking change in ARDS severity, which was achieved in less than 20% of events.<\/p>\n

Conclusions<\/h3>\n

The use of SpO2<\/sub>\/FiO2<\/sub>\u00a0interchangeably with PaO2<\/sub>\/FiO2<\/sub>\u00a0for severity classification and monitoring of ARDS is limited by its inadequate trending ability and high dependence on FiO2<\/sub>\u00a0settings, which may influence treatment decisions and patient selection in clinical trials.<\/p>\n

Key Points<\/h3>\n
    \n
  1. Misclassification of ARDS Severity by SpO\u2082\/FiO\u2082:<\/strong> The study found that SpO\u2082\/FiO\u2082 misclassified ARDS severity in 33% of cases, with 84% of misclassifications resulting in overestimation of severity compared to the PaO\u2082\/FiO\u2082 ratio.<\/li>\n
  2. Dependence on FiO\u2082 Settings:<\/strong> The SpO\u2082\/FiO\u2082 ratio was highly dependent on FiO\u2082 settings, leading to inaccurate classification. The study observed the lowest accuracy (22%) when FiO\u2082 was set at 70%, suggesting that treatment-related FiO\u2082 changes could distort severity assessment.<\/li>\n
  3. Poor Trending Ability for Disease Progression:<\/strong> The SpO\u2082\/FiO\u2082 ratio failed to reliably track changes in ARDS severity over time, correctly identifying severity progression in only 19.6% of cases. This limitation affects its utility for monitoring ARDS patients.<\/li>\n
  4. Comparison with PaO\u2082\/FiO\u2082 Ratio:<\/strong> While SpO\u2082\/FiO\u2082 correlated moderately with PaO\u2082\/FiO\u2082 (r = 0.69), it demonstrated significant variability, making it unreliable for direct substitution.<\/li>\n
  5. Influence of Oxygen Saturation Variability:<\/strong> SpO\u2082 values were affected by measurement biases, including sensor variability and perfusion status. The study found a mean SpO\u2082 overestimation bias of +0.5% compared to SaO\u2082, with greater discrepancies at higher oxygen saturations.<\/li>\n
  6. Limitations in Conversion Equations:<\/strong> Various conversion formulas used to estimate PaO\u2082\/FiO\u2082 from SpO\u2082\/FiO\u2082 performed inconsistently. The equation from Rice et al. showed the best fit, but no single model provided a precise conversion.<\/li>\n
  7. Challenges in Resource-Limited Settings:<\/strong> While SpO\u2082\/FiO\u2082 is proposed for ARDS diagnosis in settings without ABG availability, its inaccuracies may lead to over- or under-diagnosis, affecting treatment decisions.<\/li>\n
  8. Impact on Clinical Trials and Research:<\/strong> The study warns that using SpO\u2082\/FiO\u2082 as an alternative to PaO\u2082\/FiO\u2082 in clinical trials may introduce bias, impacting patient selection and outcome interpretation.<\/li>\n
  9. Recommendations for Improving Accuracy:<\/strong> To minimize misclassification, the authors suggest using SpO\u2082\/FiO\u2082 only when SpO\u2082 is below 97% and optimizing FiO\u2082 settings to avoid artificial severity inflation.<\/li>\n
  10. Future Research and Alternative Methods:<\/strong> The study advocates for exploring machine learning models and non-invasive respiratory indices to refine ARDS classification in the absence of ABG data.<\/li>\n<\/ol>\n

    ACCESS FULL ARTICLE HERE<\/strong><\/a><\/p>\n

    Open Access<\/b>\u00a0This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit\u00a0http:\/\/creativecommons.org\/licenses\/by\/4.0\/<\/a>.<\/p>\n